SLP-1004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSLP-1004
Drug Alias Nameatropisomeric dihydroanthracenoneSLP-1004
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSealife Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSealife Pharma GmbH
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A